Free Trial
OTCMKTS:AMAR

Amarillo Biosciences (AMAR) Stock Price, News & Analysis

Amarillo Biosciences logo

About Amarillo Biosciences Stock (OTCMKTS:AMAR)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
6,100 shs
Average Volume
18,253 shs
Market Capitalization
$25.24 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive AMAR Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Amarillo Biosciences and its competitors with MarketBeat's FREE daily newsletter.

AMAR Stock News Headlines

Amarillo native earns Rising Star award
I was wrong about Trump
I made a mistake. A mistake I feel very foolish about. After speaking with Donald Trump and some of his advisors, I believed him. I believed the promise that he would finally confront the single most dangerous threat to American life. That he would fix the ticking time bomb I’ve been warning about for 15 years. But I was wrong.
See More Headlines

AMAR Stock Analysis - Frequently Asked Questions

Amarillo Biosciences, Inc. (OTCMKTS:AMAR) announced its earnings results on Wednesday, November, 14th. The company reported ($0.01) EPS for the quarter. The business earned $0.02 million during the quarter.

Shares of AMAR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Amarillo Biosciences investors own include Fulcrum Therapeutics (FULC), Cerecor (CERC), Neos Therapeutics (NEOS), VIVUS (VVUS), AquaBounty Technologies (AQB), Astria Therapeutics (ATXS) and CymaBay Therapeutics (CBAY).

Company Calendar

Last Earnings
11/14/2018
Today
7/05/2025

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Sector
Medical
Industry
Pharmaceutical Preparations
Sub-Industry
N/A
Current Symbol
OTCMKTS:AMAR
Fax
N/A
Employees
2
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$1.45 million
Net Margins
-41,453.98%
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$20 thousand
Price / Cash Flow
N/A
Book Value
($0.03) per share
Price / Book
N/A

Miscellaneous

Free Float
N/A
Market Cap
$25.24 million
Optionable
Not Optionable
Beta
-0.06

Social Links

Metaverse Stocks And Why You Can't Ignore Them Cover

Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report

This page (OTCMKTS:AMAR) was last updated on 7/5/2025 by MarketBeat.com Staff
From Our Partners